<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00540488</url>
  </required_header>
  <id_info>
    <org_study_id>SRDB09</org_study_id>
    <nct_id>NCT00540488</nct_id>
  </id_info>
  <brief_title>Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional Formulas</brief_title>
  <official_title>Randomized, Double Blind, Three Way Crossover Comparison of Glucose and Insulin Responses During a Meal Glucose Tolerance Test in Subjects With Type 2 Diabetes Consuming Disease-Specific Versus Standard Nutritional Formula</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <brief_summary>
    <textblock>
      To measure and compare the glycemic and insulinemic responses of subjects consuming a&#xD;
      standard and two diabetes-specific products.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2002</start_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adjusted area under the curve (adj-AUC) of glucose response</measure>
    <time_frame>0-240 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adjusted peak for glucose and insulin response;peak time for glucose and insulin response; Adj-AUC for insulin response; change in glucose and insulin; subjective gastrointestinal tolerance</measure>
    <time_frame>0 - 240 minutes</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">54</enrollment>
  <condition>Diabetes Mellitus Type 2</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Adult enteral formula</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  signed and dated informed consent&#xD;
&#xD;
          -  18-75 years of age&#xD;
&#xD;
          -  history of type 2 diabetes&#xD;
&#xD;
          -  males and non-pregnant, non-lactating females&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  subject uses insulin for glucose control&#xD;
&#xD;
          -  significant cardiovascular event &lt;12 weeks prior to study entry&#xD;
&#xD;
          -  active malignancies&#xD;
&#xD;
          -  history of end stage renal disease&#xD;
&#xD;
          -  history of organ transplant&#xD;
&#xD;
          -  current hepatic disease&#xD;
&#xD;
          -  intervention for HIB&#xD;
&#xD;
          -  takes niacin&#xD;
&#xD;
          -  history of gastroparesis&#xD;
&#xD;
          -  active disease that may interfere with nutrient intake&#xD;
&#xD;
          -  allergy or intolerance to ingredients in the study products&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Carolyn Alish, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Protocare Trials, Chicago Center for Clinical Research</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>North Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2007</verification_date>
  <study_first_submitted>October 5, 2007</study_first_submitted>
  <study_first_submitted_qc>October 5, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2007</study_first_posted>
  <last_update_submitted>October 12, 2007</last_update_submitted>
  <last_update_submitted_qc>October 12, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 15, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

